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Background: The R2 repeat region of GLURP has been reported as a good genetic marker for Plasmodium
falciparum genotyping. Proper knowledge of the extent and nature of P. falciparum genetic diversity using highly
immunogenic R2 repeat region in malaria-endemic areas is a crucial element to understand various aspects related
to immunity acquisition and disease pathogenesis.
Methods: Population diversity of P. falciparum GLURP and amino acid sequence repeats in GLURP R2 region was
studied in malaria-endemic Assam state, northeast India and compared at an interval of five years during 2005
(Group-A) and 2011 (Group-B).
Results: Of the 66 samples, a total of 55 samples showed positive PCR bands for GLURP R2 region and altogether
ten types of alleles with size ranging from 501 bp to 1,050 bp (50 bp bin) were observed and coded as genotypes
I-X. In Group-A (n = 29), 24 samples were found infected with single, four with double and one with triple P. falciparum
genotype, while in Group-B (n = 26), single genotype was found in 23 samples, double in two samples and triple in
one sample. Genotype IV showed significant increase (p = 0.002) during 2011 (Group-B). Genotypes I to V were more
common in Group-B (62%), however genotypes VI to X were more frequently distributed in Group-A. The expected
heterozygosity was found slightly higher in Group-A (HE = 0.87) than Group-B (HE = 0.85), whereas multiplicity of
infection (MOI) in Group-A (MOI = 1.21 ± 0.49) and Group-B (MOI = 1.12 ± 0.43) did not display significant variation.
The amino acid repeat sequence unit (AAU) DKNEKGQHEIVEVEEILPE (called ‘a’) was more frequent in the well-conserved
part of R2 repeat region.
Conclusion: The present study is the first extensive study in India which has generated substantial data for
understanding the type and distribution of naturally evolved genetic polymorphism at amino acid sequence level in
GLURP R2 repeat region in P. falciparum. There was decrease in the PCR amplicon size as well as the number of AAU
[amino acid repeat unit] in Group-B displaying the bottleneck effect. The present study described a new type of AAU ‘d’
which varied from the other previous known AAUs.
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GLURP (glutamate rich protein) is a 220-KDa exo-antigen
expressed in both pre-erythrocytic and erythrocytic stages
of Plasmodium falciparum, as well as on the surface of
newly released merozoites in human host [1]. It is highly
immunogenic and serves as target for antibodies involved
in antibody-dependent cellular inhibition (ADCI) in the
presence of monocytes [2]. In ADCI, the cytophilic anti-
bodies (mainly IgG3 and IgG1) act in synchronization
with monocytes to control Plasmodium multiplication [3].
Immuno-epidemiological studies conducted in different
endemic areas have showed high levels of GLURP anti-
bodies in malaria-infected humans, which were found to
provide protection against high parasitaemia and clinical
disease [4,5]. The gene encoding GLURP in P. falciparum
consists of three regions namely, N-terminal non-
repetitive region (R0), central repetitive region (R1) and
an immunodominant C-terminal repetitive region (R2)
[1]. The recombinant P. falciparum GLURP non-repeat
R0 and repeat R2 regions expressed in Escherichia coli
were found to induce a humoral response in vivo [6]. A
recent study on naive Dutch volunteers have shown
that antibody level against R2 repeat region of GLURP
in plasma was found much higher than that of R1 and
R0 regions [7]. The studies further suggested that R2
repeat region plays an important role in inducing
protective immunity against P. falciparum malaria. The
R2 repeat region has been reported as a good genetic
marker for P. falciparum genotyping and also for differ-
entiating new infection from recurring infections [8].
Therefore, knowledge of the extent and nature of P.
falciparum genetic diversity in malaria-endemic areas is
a crucial element in understanding various aspects related
to immunity acquisition and disease pathogenesis.
Northeastern states of India report high P. falciparum
cases and malaria-attributed deaths annually [9,10]. The
entire northeast region has unique geography conducive to
malaria spread and also its poor socio-economic conditions
increase transmission risk [11-13]. In India, P. falciparum
population diversity has been studied using MSP1, MSP2
and CSP markers [14-16], however, no study on diversity
of GLURP R2 has been reported. The current study was
carried out in the malaria-endemic Assam state of
northeast India to understand the population diversity
of P. falciparum GLURP and amino acid sequence
repeats in GLURP R2 region using the samples collected
during the peak malaria periods in 2005 and 2011.
Methods
Study site
The present study was conducted in the forest-fringed
Orang public health centre (PHC) area (92°10’40”E
longitude to 92°21’20”N latitude) of Udalguri district in
Assam. The study area has many tea gardens andevergreen dense forests and experiences high annual
rainfall (1,500-2,000 mm), and humidity (82-88%). The
temperature ranges from 13.5°C in winter to 34.5°C in
summer. The area reports perennial malaria and the
inhabitants are socio-economically backward mixed popu-
lation of Bodos, Nepalese, Adivasis and Rabhas [12,13].
The blood samples for the present study were collected
during April-September in 2005 and 2011.
Sample collection and DNA extraction
Malaria-positive samples were collected from PHC and
health camps organized by Assam State Government
health department. Patients with clinical symptoms of
malaria were examined using malaria rapid detection kit
(Optimal IT®, Diamed GmbH, Switzerland and First
Sign® Avantor Performance Materials India, Pvt Ltd) in
the field while smears were obtained on glass slide for
microscopy. A few drops of blood from rapid detection
kit confirmed P. falciparum infections were taken in
FTA™ classic cards (Whatman, Sweden) for molecular
analysis. The blood-blotted FTA™ cards were air dried,
labelled and stored in dried condition. For long-term
storage, FTA™ cards were stored in airtight containers
in −20°C. Microscopy confirmed dried FTA™ card samples
were used to extract DNA for PCR diagnosis of malaria
parasites. A small portion of the blood-blotted FTA cards
were cut using Harris Micro Punch™ (Whatman, USA)
and taken in a 2.0 ml centrifuge tube. DNA extraction was
carried out using Qiagen Blood Mini Kit (Qiagen AG,
Germany) following the standard manufacturer protocol.
In the present study, 38 samples were collected in 2005
(Group-A) while 46 sample were collected in 2011
(Group-B). Mean age (mean ± SD) of the study partici-
pants for Group-A was 22 ± 2.9 years and for Group-B
was 13 ± 1.6 years. The male/female ratio in Group-A and
Group-B samples was 1.06 and 1.36, respectively.
PCR assay
All samples were put for species-specific nested PCR
assay for detection of the different Plasmodium species,
following the reaction conditions described previously
[9,17]. The samples confirmed for P. falciparum were
genotyped for polymorphic GLURP R2 repeat region by
semi-nested PCR reaction using the following set of






The resultant amplicons were electrophoresed in 2%
agarose gel (Sigma Aldrich, USA) and PCR product sizes
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USA) under UV transilluminator system (Syngene G-Box,
UK). DNA fragments obtained were grouped into 50 bp
bins and each band of distinct size was considered as differ-
ent allele. Selected amplicons from each year were purified
using GenElute™ gel extraction kit (Sigma Aldrich, USA)
according to the manufacturer’s protocol. Purified products
were then sequenced at Biolink Pvt Ltd, New Delhi, India
using an ABI3730XL DNA sequencer (Applied Biosystem)
with GNF and GOR primers, respectively.
Sequence analysis
Alignment of nucleotide sequences and translation to
reverse complementary sequences were carried out using
BioEdit computer program (v7.1.3.0). Comparison of
aligned nucleotide sequences was made with those
available in NCBI’s GenBank database using BLASTn
with program selection optimized for highly similar
sequences (megablast). The newly generated sequences
were deposited in GenBank (accession number: KJ664815-
29, KJ664831-36, KJ645966 and KJ719442). Nucleotide
sequences were translated using Expasy online software
and the obtained amino acid sequences were compared
with available sequences in the NCBI database (accession
number: XM001347592, M59706, AF247634, AF191065-
67, AY138510-11) using CLUSTAL-W of the MEGA 5.1
software package [19] and manually adjusted wherever
necessary.
Statistical analysis
The allelic frequency was calculated by dividing the
number of a particular allele by the total number of
samples positive for that allelic family of the gene [20].
The multiplicity of infection (MOI) was calculated by
dividing the total number of fragments detected in
GLURP by the number of samples positive for the same
marker. Heterozygosity, which represents the probability
of being infected by two parasites with different alleles
at a given locus and ranging between 0 and 1, was calcu-
lated by using the following formula- HE = [n/(n − 1)]
[(1 − ∑pi2)], where ‘n’ is the number of isolates sampled
and ‘pi’ is the allele frequency at a given locus [21].
Isolates with more than one genotype were considered as
polyclonal infection, while the presence of a single allele
was considered as monoclonal infection. Quantitative data
were expressed as the mean ± standard deviation (SD)
and were compared using Student’s unpaired ‘t’ test.
Qualitative data were compared using Fisher’s exact
test. Statistical analysis was performed using GraphPad
InStat (Ver. 3.05, USA).
Ethical consideration
The study protocol was approved by the Medical Ethics
Committee of LGB Regional Institute of Mental Health(under Government of India, Ministry of Health and
Family Welfare) Tezpur, Assam, India. Participants were
clearly explained the objectives of the study and enrolled
for the study only after consent.
Results
Allelic diversity
Altogether, 84 samples were analysed in the present
study, of which 38 were collected in 2005 (Group-A)
and 46 in 2011 (Group-B). The age (mean ± SD) of the
participants of Group-A was 22 ± 2.9 years while Group-
B was 13 ± 1.6 years. Out of 84 samples, 66 confirmed
for P. falciparum mono-infection were used for GLURP
genotyping, of which 55 samples showed positive PCR
amplification for GLURP R2 region. Ten types of differ-
ent alleles with size ranging from 501 bp to 1,050 bp
(50 bp bin) were observed and coded as genotypes I-X
(Table 1). Of the 66 samples, 29 from Group-A and 26
from Group-B were successfully genotyped for GLURP
R2 locus (Figure 1). In Group-A (n = 29), 24 samples
were found infected with single, four with double and
one with triple P. falciparum genotype (Figure 1a). In
Group-B (n = 26), a single genotype was found in 23
samples, double in two samples and triple in one sample
(Figure 1b). Overall, eight types of genotype in Group-A
and nine in Group-B were found in the present study. In
Group-A, genotype I and II were not found while in
Group-B genotype X could not be recorded. Frequency
of genotype IV was high in Group-A (34%), while geno-
type VIII was most frequently (23%) found among the
samples in Group-B. Genotype IV showed significant
increase (p = 0.002) during 2011 (Group-B) whereas the
other genotypes did not show significant variation
between the two study years (p > 0.05) (Figure 2 and
Table 1). Further, the genotypes I to V (those size <801 bp)
were found to be more common in Group-B (62%), while
the genotypes VI to X (size ≥801 bp) were more frequently
distributed in Group-A (86%). The expected heterozy-
gosity was found slightly higher in Group-A (HE = 0.87)
compared to Group-B (HE = 0.85). Similarly, the MOI in
Group-A (MOI = 1.21 ± 0.49) and Group-B (MOI = 1.12 ±
0.43) did not display significant variation.
Amino acid sequence diversity of GLURP R2 repeat region
R2 locus of GLURP gene from randomly selected samples
from both the groups (Group-A = 9; Group-B = 14) were
sequenced. There was considerable variation in the length
of R2 repeat region among the isolates of both groups
(Figure 1a and b). The amino acid repeat sequence unit
(AAU) DKNEKGQHEIVEVEEILPE (called ‘a’) was present
more frequently in the well-conserved part of R2 repeat
region. Apart from this, three other types of AAU were
also detected in which GQ [glycine-glutamine] amino acid
positions at sixth and seventh were replaced by amino
Table 1 Allelic size variants of GLURP R II repeat region of P. falciparum field isolates in Group-A (collected in 2005)
and Group-B (collected in 2011)
Types Allelic size variants (50 bp bin) Group-A (N = 29) n (%) Group-B (N = 26) n (%) Total (N = 55) N’ (%) p value
I 501-550 0 2(7) 2(3) 0.2014
II 601-650 0 1(4) 1(2) 0.4531
III 651-700 1(3) 3(10) 4(6) 0.3211
IV 701-750 1(3) 10(34) 11(17) 0.0016
V 751-800 3(9) 2(7) 5(8) 1
VI 801-850 5(14) 1(4) 6(9) 0.209
VII 851-900 6(17) 3(10) 9(14) 0.4943
VIII 901-950 8(23) 4(14) 12(19) 0.5221
IX 951-1000 7(20 3(10) 10(16) 0.3268
X 1001-1050 4(11) 0 4(6) 0.1198
I + II + III + IV + V 5(14) 18(62) 23(36) 0.0001
VI + VII + VIII + IX + X 30(86) 11(38) 41(64) 0.0001
Total 35(100) 29(100) 64(100) 0.3768
MOI 1.21 ± 0.49 1.12 ± 0.43 1.16 ± 0.46
N = number of sample; n = frequency of GLURP allelic size variants;
% = percentage of GLURP allelic size variants; MOI =multiplicity of infection.
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tamine] (called ‘c’), and additionally a new type of AAU
was found, where amino acids VE were present in sixth
and seventh position, while amino acid D [aspartic acid]
was found in 14th position (called ‘d’). However, an extra
D or E amino acid was found in between some AAUs
(Additional file 1). While comparing with the available
NCBI database sequences, a total 20 different types of
haplotypes were observed and designated as T1-T20
(Additional file 2). Six and eight different haplotypes were
observed in Group-A and B, respectively, while NCBI
database showed seven haplotypes only. Haplotype T8 was
common in both the groups and found in maximum
number of samples (n = 3) as compared to T9 (n = 2), T10
(n = 1), T11 (n = 1), T12 (n = 1) and T13 (n = 1) in Group-
A. However in Group-B T14 (n = 4) and T16 (n = 4)
haplotypes were found in high number (Additional file 2).
The arrangement of repeat amino acid unit varied
among the isolates, however in the first four position, b-
a-c-a arrangement was found in majority of the samples
in Group-A (n = 7; 77.8%) compared to Group-B (n = 7;
50%) (Additional file 1). However in NCBI [National
Centre for Biotechnology Information] sequences only
one sequence had b-a-c-a arrangement of amino acid
unit. In all the three groups (reference NCBI sequences,
Group-A and B) b-a-c-a and b-c-c-a arrangements were
common, whereas b-c-a-c arrangement was unique in
Group-A, b-a-d-a and b-a-a-a were unique in Group-B,
and b-c-c-c, b-c-b-a and .-.-c-a repeat amino acid unit
arrangements were unique in the NCBI sequences. All the
samples taken currently and NCBI sequences contained ‘a’
type AAU in high frequency as compared to b, c and d typeAAUs. The ‘d’ type of AAU was present in Group-B only
and could not be found in Group-A and NCBI sequences.
In the present study, a total of seven types of amino
acid repeat pair order (AAUO) were found and desig-
nated as ‘T’ to ‘Z’, with an extra presence of 20th amino
acid either D (aspartate) or E (glutamate) located in
between the repeat units as shown in Additional file 2.
Of the seven AAUOs, six types were common in both
the Groups and NCBI sequences, except ‘T’ type which
was found in Group-B only. The ‘Y’ type AAUO was
found in high number in all the groups as compared to
other AAUO (T, U, V, W, X, and Z) (Additional file 2).
However the average of ‘Y’ per sample in Group-A
(2.6 ± 1.4) was statistically high than Group-B (1.2 ± 1.0)
(p = 0.01), while ‘V’ was found to be higher in Group-B
(0.5 ± 0.5) than Group-A (0.1 ± 0.3) (p = 0.04). Among the
extra ‘D’ and ‘E’ amino acids, only ‘E’ showed significant
variation between Group-A and -B (p = 0.03). Further,
while comparing total AAUs, AAUOs and presence of
extra ‘D’ and ‘E’ amino acids in isolates of Group-A and B,
the mean AAUOs were significantly higher in Group-A
(4.2 ± 0.8) than Group-B (3.4 ± 0.8) (p = 0.03). The
comparison of amino acid repeat sequences of total
samples from both the experiment Groups (A and B),
with the reference NCBI sequences, revealed that the
average frequency distribution of AAUO ‘U’ was stastically
higher in the reference sequences (0.3 ± 0.5) (p = 0.04)
(Additional file 2).
Discussion
The current study has suggested considerable polymorph-
ism and variation in the genetic sequences of P. falciparum
Figure 1 Molecular size variation of GLURP R2 repeat regions of Plasmodium falciparum field isolates (Group A and B).
Kumar et al. Malaria Journal 2014, 13:450 Page 5 of 8
http://www.malariajournal.com/content/13/1/450GLURP R2 repeat region among the samples collected
after an interval of five years in a P. falciparum malaria-
endemic setting in the northeastern region of India. Manystudies have indicated that genetic diversity and multipli-
city of Plasmodium species was responsible for the
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Figure 2 Frequency (%) distribution of allelic size variants of P. falciparum GLURP R2 repeat region in Group-A (collected in 2005) and
Group-B (collected in 2011).
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the ability to evade human immune response but also
helps in developing resistance to anti-malarial drugs
[24,25]. Plasmodium falciparum has shown decreased
susceptibility to all major anti-malarial drugs in different
regions of the world [10,26,27]. Various malaria vaccine
candidate antigens are in different stages of clinical trials,
of which circumsporozoite protein (CSP) antigen-based
RTS,S vaccine is under phase-3 trial and the results
have showed moderate efficacy against both clinical and
severe malaria among the young infants [28]. However,
significant heterogeneity in vaccine efficacy was seen
across different trial sites [29], probably due to genetic
polymorphism of P. falciparum CSP gene in different
geographical regions [30].
Malaria parasite P. falciparum has many polymorphic
loci that have been used to study genetic diversity
[21,22,30]. GLURP has been considered an important
antigen that has been playing an important role in the
induction of protective immunity against P. falciparum
malaria [7]. However, only a few studies have been
conducted on conserved amino acid sequences of R2
repeat region of GLURP from field sample isolates of
P. falciparum, but none of the studies has reported the
polymorphism and amino acid repeat order of GLURP
in India [31]. The present study is first extensive attempt
to understand the: (i) overall population diversity of P.
falciparum; (ii) changes in the population within this time
period; and, (iii) arrangement of amino acid sequence
pair repeat in R2 region of Pf GLURP gene over the
time interval of five years in the study area. There has
been a non-significant decrease in the MOI in 2011, but agenetic drift in P. falciparum population over the time,
which could be due to the change in the anti-malarial
drug policy in northeast India during 2007–08 [32,33].
Previous studies have reported two GLURP (R2) alleles
in Honduras [34], three in French Guyana [35] and each
four in Colombia [36] and Brazil [37] in the area of low
endemicity; however in high endemicity areas in Africa
and Asia, anywhere from eight in India to twenty
GLURP alleles in Sudan were reported respectively
[18,20,21,38]. Current study found eight alleles in
Group-A and nine alleles in Group-B, whereas overall
ten alleles were found in the total samples compared to
eight reported in Orissa [20]. The present study has
emphasized that the amplicons size of R2 repeat region
in Group-A was larger than Group-B, but the frequency
of genotype IV was found to increase in Group-B. A pre-
vious study suggested that increase in allele frequency
may arise as a result of selection induced due to drug
pressure and other control strategies [39].
The results suggest that amino acid sequence DKNEKG
QHEIVEVEEILPE ‘a’ was present more frequently in the
well-conserved part of P. falciparum GLURP R2 repeat
region. Present results were similar to a previous study,
which showed that GQ in sixth and seventh position is
replaced by VE ‘b’ and VQ ‘c’, respectively [1]. However,
the present study has found a new type of amino acid
sequence pair VE in sixth and seventh position and D
in 14th position and termed as ‘d’. There were thirteen
different haplotypes found among the twenty three
sequenced isolates when compared with the amino acid
sequence of 3D7 as standard sequence in the present
study [40]. On comparing present sequences with the
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ber of conserved repeat amino acid pairs were found in
Group-A (n = 12) compared to Group-B (n = 11) and
NCBI sequences (n = 11). Many studies have reported that
the conserved repeat sequences were found to vary among
the isolates [20,30,37]. There were thirteen different types
of haplotype found in the entire field samples, while only
seven haplotypes were found in NCBI sequences, of which
about 50% contained b-a-c-a in the first four positions.
The haplotypes found in NCBI sequences (T1-T7) were
different from each other as well as from the present
sequences. The most common AAU found in the two
Groups was ‘a’ (DKNEKGQHEIVEVEEILPE) type followed
by ‘c’ (DKNEKVQHEIVEVEEILPE), ‘b’ (DKNEKVEHEIVE-
VEEILPE) and d’ (DKNEKVEHEIVEVDEILPE), respect-
ively. Similar to the present results, the ‘a’ type AAU was
also predominant among the NCBI sequences. On the
other hand, ‘d’ was present in four samples in Group-B but
not found in NCBI sequences. The most predominant type
of AAUO found in present samples as well as in the NCBI
sequences was ‘Y’ (c-a) type, however ‘T’ (d-a) type was
present in four samples in Group-B only. The results indi-
cate that there has been increase in the frequency of sample
having ‘d’AAU and ‘T’AAUO during 2011, however many
of the AAU and AAUO did not show variation, suggesting
that the sequence units and orders are homologues with
the NCBI sequences from other countries. A previous
study conducted on sequence analysis of GLURP in
China has revealed that the native sequences were similar
to the overseas sequences, which suggests the sequences
homology [31]. The conservation in sequences could
efficiently be used to target P. falciparum in different
malaria-endemic areas globally. The present study how-
ever revealed that the number of AAU did not differ
over the period of time but the arrangement of AAUO
differed, which can be attributed to the change in the
anti-malarial drug policy for northeastern states during
2007–08. In the previous studies similar observations
were recorded in Malawi where the chloroquine wild
genotype was restored after thirteen years of withdrawal
of chloroquine from malaria control programmes [41].
The present study is the first extensive study in India
which has generated substantial data for understanding
the type and distribution of naturally evolved genetic
polymorphism at amino acid sequence level in GLURP
R2 repeat region. The PCR amplicons size as well as the
number of AAU decreases in the samples of Group-B,
displaying the bottleneck effect under anti-malarial drug
pressure. Sequence analysis of selected samples showed
considerable haplotypic diversity. The present study
described a new type of AAU ‘d’ which varied from
other previously known AAUs (a, b and c). The amino
acid repeat pattern at first four positions was common
in both the experiment Groups and NCBI sequences.Present data could also be useful in monitoring the P.
falciparum population in order to check new strains.
Amino acid repeat pattern of GLURP R2 repeat region
of P. falciparum from other countries would be useful in
understanding diversity and identifying homology among
the different isolates.
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